Agilent ( A ) Down 2.5% Since Last Earnings Report: Can It Rebound?
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Keysight ( KEYS ) is a Top-Ranked Momentum Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Looking Into Agilent Technologies's Recent Short Interest - Agilent Technologies ( NYSE:A )
Agilent Technologies's A short interest as a percent of float has risen 6.09% since its last report. According to exchange reported data, there are now 3.04 million shares sold short, which is 1.22% of all regular shares that are available for trading.
Chromatography Technologies Powering the Future of Biopharmaceuticals
Boston, Sept. 23, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, the "Chromatography in Pharmaceuticals and Biotechnology: Global Markets" is projected to grow from $13.3 billion in 2025 to $19.8 billion by the end of 2030, at a compound annual growth rate ( CAGR ) ...
Strength in Network Software Drives Roper: Can the Momentum Sustain?
ROP lifts its 2025 outlook as the Network Software and Application Software segments gain from GenAI, cross-sell and strong demand.
GEHC or A: Which Is the Better Value Stock Right Now?
GEHC vs. A: Which Stock Is the Better Value Option?
Here's How Much You'd Have If You Invested $1000 in Keysight a Decade Ago
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Proscia Unveils Aperture, Making the Moment of Diagnosis the Gateway to Life-Saving Treatments for More Patients
Enables biopharmaceutical companies to accelerate precision drug development by delivering real-time patient insights from a global laboratory network on track to diagnose 8 million pathology cases annually. Opens new streams of revenue for diagnostic laboratories while growing their strategic ...
GEHC or A: Which Is the Better Value Stock Right Now?
GEHC vs. A: Which Stock Is the Better Value Option?
Why Agilent ( A ) International Revenue Trends Deserve Your Attention
Evaluate Agilent's (A) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Here's Why Keysight ( KEYS ) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Agilent Q3 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
A posts fiscal Q3 earnings and revenue beats, with double-digit sales growth and upbeat guidance lifting shares.
Agilent Reports 10% Revenue Jump in Q3
Agilent Technologies ( NYSE:A ) , a global leader in laboratory instruments and scientific solutions for life sciences and diagnostics, released its Q3 fiscal 2025 results on Aug. 27, 2025. The company delivered revenue of $1.74 billion, coming in over its own projected revenue guidance and ...
Agilent Raises Outlook on Q3 Growth
Agilent Technologies ( NYSE:A ) reported Q3 FY2025 revenue of $1.74 billion, up 6.1% year-over-year on a core basis, with non-GAAP EPS of $1.37, both exceeding guidance. The company raised its full-year revenue outlook to $6.91 billion-$6.93 billion ( core growth 4.5% at midpoint ) , despite ...
Agilent Technologies ( A ) Surpasses Q3 Earnings and Revenue Estimates
Agilent (A) delivered earnings and revenue surprises of +0.74% and +4.60%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
S&P 500 Tests Records Ahead Nvidia Results, MongoDB Rockets - MongoDB ( NASDAQ:MDB )
Wall Street trades cautiously as investors await Nvidia's earnings, with major indices hovering near record highs. Nvidia stock edges up 0.1%; traders eye Blackwell chip growth, China updates and margins as key drivers.
[Latest] Global Chemical Reagents Market Size/Share Worth USD 26.5 Billion by 2034 at a 7.5 CAGR: Custom Market Insights ( Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis )
Austin, TX, USA, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "Chemical Reagents Market Size, Trends and Insights By Product Type ( Solvents, Acids & Bases, Oxidizing & Reducing Agents, Buffers & Standards, Catalysts ) , By Application ( ...
Unveiling Agilent ( A ) Q3 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Agilent (A), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2025.
Genome Editing Market to Grow at 16.9% CAGR Through 2030
Boston, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, the "Genome Editing: Technologies and Global Markets" is projected to grow from $10.8 billion in 2025 to $23.7 billion by the end of 2030, at a compound annual growth rate ( CAGR ) of 16.9% during the ...
Allurion Technologies, Inc. ( ALUR ) Reports Q2 Loss, Misses Revenue Estimates
Allurion Technologies, Inc. (ALUR) delivered earnings and revenue surprises of +12.31% and -43.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GEHC or A: Which Is the Better Value Stock Right Now?
GEHC vs. A: Which Stock Is the Better Value Option?
Rockwell Medical ( RMTI ) Reports Q2 Loss, Tops Revenue Estimates
Rockwell Medical (RMTI) delivered earnings and revenue surprises of 0.00% and +1.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Sanara MedTech Inc. ( SMTI ) Reports Q2 Loss, Tops Revenue Estimates
Sanara MedTech (SMTI) delivered earnings and revenue surprises of +30.30% and +1.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Baculovirus Expression System Market Poised for Significant Growth, Estimate to Hit USD 781.8 Million by 2032 | Coherent Market Insights
Burlingame, CA, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- The global Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn in 2032, exhibiting a compound annual growth rate ( CAGR ) of 8.7% from 2025 to 2032.
TerrAscend Corp. ( TSNDF ) Reports Q2 Loss, Beats Revenue Estimates
TerrAscend Corp. (TSNDF) delivered earnings and revenue surprises of -50.00% and +0.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Would You Ride in a Flying Car? This Company Could Make It a Reality ( and Yes, It's Publicly Traded ) .
This aviation pioneer is poised to potentially usher in transportation's next major milestone.
[Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights ( Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis )
Austin, TX, USA, July 25, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "CRISPR Gene Editing Market Size, Trends and Insights By Product ( Kits and Reagents, Services ) , By Gene Editing Modality ( Ex-Vivo Editing, In-Vivo Editing ) , By Technology ...
P/E Ratio Insights for Agilent Technologies - Agilent Technologies ( NYSE:A )
In the current session, Agilent Technologies Inc. A is trading at $115.19, after a 1.01% drop. Over the past month, the stock fell by 1.07%, and in the past year, by 14.32%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ...
What's Driving the Market Sentiment Around Agilent Technologies? - Agilent Technologies ( NYSE:A )
Agilent Technologies's A short percent of float has fallen 18.29% since its last report. The company recently reported that it has 3.35 million shares sold short, which is 1.34% of all regular shares that are available for trading.
In Situ Hybridization Market is expected to generate a revenue of USD 3.38 Billion by 2031, Globally, at 8.97% CAGR: Verified Market Research®
Lewes, Delaware, July 14, 2025 ( GLOBE NEWSWIRE ) -- The Global In Situ Hybridization Market Size is projected to grow at a CAGR of 8.97% from 2024 to 2031, according to a new report published by Verified Market Research®.
Here's How Much a $1000 Investment in Agilent Technologies Made 10 Years Ago Would Be Worth Today
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Do Options Traders Know Something About Agilent Technologies Stock We Don't?
Investors need to pay close attention to Agilent Technologies stock based on the movements in the options market lately.
's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Alcoa ( NYSE:AA ) , Agilent Technologies ( NYSE:A )
The Benzinga Stock Whisper Index highlights five stocks each week seeing more interest from readers than normal. Tariffs could impact one of the company's on the list in their next financial results. Geopolitical tensions, Fed uncertainty, and fast-moving headlines are driving July volatility.
Why Is Agilent ( A ) Up 5.4% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Laboratory Information Management System Market worth US$5.19 billion by 2030 with 12.5% CAGR | MarketsandMarkets™.
Delray Beach, FL, June 27, 2025 ( GLOBE NEWSWIRE ) -- The global laboratory information management system market, valued at US$2.54 billion in 2024, stood at US$2.88 billion in 2025 and is projected to advance at a resilient CAGR of 12.5% from 2025 to 2030, culminating in a forecasted valuation ...
Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors
CAMBRIDGE, Mass., June 25, 2025 ( GLOBE NEWSWIRE ) -- Arbor Biotechnologies™, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Mikael Dolsten, M.D., Ph.D., to its Board of Directors.
Looking Into Agilent Technologies's Recent Short Interest - Agilent Technologies ( NYSE:A )
Agilent Technologies's A short percent of float has fallen 5.17% since its last report. The company recently reported that it has 4.14 million shares sold short, which is 1.65% of all regular shares that are available for trading.
Here's How Much You'd Have If You Invested $1000 in Agilent Technologies a Decade Ago
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board
NEW YORK and PARIS, June 18, 2025 ( GLOBE NEWSWIRE ) -- Rarecells, Inc., a leader in liquid biopsy technology, is pleased to announce the appointment of Dr. Rita Shaknovich to its Scientific Advisory Board. Dr. Shaknovich brings over 20 years of leadership experience across private industry and ...
Genomics Market to Hit US$66.8 Billion by 2029 with 9.4% CAGR | MarketsandMarkets™.
Delray Beach, FL, June 11, 2025 ( GLOBE NEWSWIRE ) -- The global genomics market, valued at US$42.4 billion in 2023, stood at US$42.6 billion in 2024 and is projected to advance at a resilient CAGR of 9.4% from 2024 to 2029, culminating in a forecasted valuation of US$66.8 billion by the end of ...
Don't Overlook Agilent ( A ) International Revenue Trends While Assessing the Stock
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Company News for May 30, 2025
Companies in The News Are: A, ...
Agilent Q2 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
A's second-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns.
Veeva Systems, e.l.f. Beauty, C3.ai, BRP And Other Big Stocks Moving Higher On Thursday - Agilent Technologies ( NYSE:A ) , C3.ai ( NYSE:AI )
U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 100 points on Thursday. Shares of Veeva Systems Inc. VEEV rose sharply during Thursday's session following strong quarterly results. The company reported adjusted earnings per share of $1.97, beating the analyst consensus ...
Agilent Braces For Potential US-EU Tariff Hike, Maintains Annual Outlook - Agilent Technologies ( NYSE:A )
Q2 adjusted EPS rose to $1.31 vs. $1.26 consensus, up from $1.22 a year ago. Agilent ups FY25 revenue forecast to $6.73 billion-$6.81 billion, from prior $6.68 billion-$6.76 billion. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and stock ideas-now 60% off for ...
Agilent Technologies ( A ) Q2 Earnings and Revenues Top Estimates
Agilent (A) delivered earnings and revenue surprises of 3.97% and 2.64%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Judy Brown Of Agilent Technologies Shows Optimism, Buys $182K In Stock - Agilent Technologies ( NYSE:A )
Judy Brown, Board Member at Agilent Technologies A, reported an insider buy on May 23, according to a new SEC filing. What Happened: Brown made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the U.S. Securities and Exchange Commission.
Positive Signal: Pascal Soriot Shows Faith, Buying $182K In Agilent Technologies Stock - Agilent Technologies ( NYSE:A )
Pascal Soriot, Director at Agilent Technologies A, reported an insider buy on May 23, according to a new SEC filing. What Happened: Soriot made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the U.S. Securities and Exchange Commission.
Curious about Agilent ( A ) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.
Digital PCR and Real-Time PCR Market Size Worth USD 17.54 billion by 2031 at 9.1% CAGR | The Insight Partners
US & Canada, May 19, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the global digital PCR and real-time PCR market is witnessing substantial growth with the surging incidence of genetic and infectious diseases and rising investments in gene ...
